Not Signed In - Decreased Bleeding Frequency With Secondary Prophylactic Use Of NovoSeven (REG) Shown
Thu, 14 Dec 2006 03:00 AM EST
... Data presented at the 48th Annual Meeting of the American Society of Hematology (ASH) from a study testing the use of NovoSeven® Coagulation Factor VIIa (Recombinant) for secondary prophylaxis in patients with hemophilia complicated by inhibitors. [click link for full article] ...
Related Topics
- Factor VIIa, Recombinant
- Bleeding Disorders
- Gastrointestinal Bleeding
- Hearing Loss
- WISE EARS!® At Work!
- WISE EARS!® Campaign to Prevent NIHL
- WISE EARS!® Tips: Hearing Matters
- Bleeding in the brain (intracranial bleeding)
- Radiation Therapy
- Hyperparathyroidism
- Decreased mobility
- Decreased vision, blindness
- Blindness, decreased vision
- Decreased ability to walk
- Decreased libido, impotence
- Decreased ability to interact with others
- Decreased ability to care for self
- Decreased production tears
- Decreased tear production
- Decreased immune response
email this page
print this page
bookmark this page
feedback on this page
